Home / Stocks / ALAB

Astera Labs (ALAB, Chipmakers) Stock Valuation & Fair Value Mixed on our tests

Astera Labs (ALAB, Chipmakers) trades at a current P/E of 97.5, about 21% below its historical normal valuation, with a forward growth estimate of 45.6% and a PEG of 2.14. Priced at its historical normal P/E of 124.0 on the same blended earnings, the 2026-10-09 close of $342.21 corresponds to about $435 a share. This is a valuation reference, not a price target.

DATA AS OF 2026-10-12
Current P/E
97.5
Normal P/E
124.0
PEG
2.14
Fwd growth
45.6%
Div yield
0.0%
RSI (14)
46.2
Neutral
Technical context
  • Price $324.11 at the 2026-10-12 close, 5.1% below the 20-day average ($341.40) and 2.0% above the 50-day ($317.72).
  • RSI (14) at 46.2.
  • 52-week range $100.27 to $483.02: the price is 32.9% below the high and 223.2% above the low.

The Street vs SeerForecast

Wall Street's mean price target for ALAB is $391.77 across 22 analysts, 20.9% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: mixed on our tests. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from weak on forward returns (2026-06-14) to mixed on our tests (2026-10-12).

Current P/E and rating by weekCurrent P/E moved from 95.7 to 97.5 between 2026-06-12 and 2026-10-09, against a normal P/E of 124.0, with 6 rating changes over 37 recorded weeks.2026-06-12: P/E 95.7, Weak on forward returns, recalculated for the week of 2026-06-142026-06-16: P/E 95.7, Weak on forward returns, recalculated for the week of 2026-06-162026-06-18: P/E 95.7, Weak on forward returns, recalculated for the week of 2026-06-212026-07-02: P/E 95.7, Weak on forward returns, recalculated for the week of 2026-07-022026-07-06: P/E 95.7, Weak on forward returns, recalculated for the week of 2026-07-062026-07-09: P/E 95.7, Weak on forward returns, recalculated for the week of 2026-07-092026-07-10: P/E 95.7, Weak on forward returns, recalculated for the week of 2026-07-122026-07-13: P/E 95.7, Weak on forward returns, recalculated for the week of 2026-07-132026-07-14: P/E 95.7, Weak on forward returns, recalculated for the week of 2026-07-142026-07-20: P/E 95.7, Weak on forward returns, recalculated for the week of 2026-07-202026-07-22: P/E 128.9, Poor on forward returns, recalculated for the week of 2026-07-222026-07-24: P/E 128.9, Poor on forward returns, recalculated for the week of 2026-07-252026-07-27: P/E 128.9, Poor on forward returns, recalculated for the week of 2026-07-272026-07-31: P/E 128.9, Poor on forward returns, recalculated for the week of 2026-07-312026-07-31: P/E 123.2, Poor on forward returns, recorded live 2026-08-032026-08-07: P/E 123.2, Poor on forward returns, recalculated for the week of 2026-08-072026-08-07: P/E 106.6, Mixed on our tests, recorded live 2026-08-102026-08-14: P/E 106.6, Mixed on our tests, recalculated for the week of 2026-08-142026-08-14: P/E 101.2, Mixed on our tests, recorded live 2026-08-172026-08-21: P/E 101.2, Mixed on our tests, recalculated for the week of 2026-08-212026-08-21: P/E 88.5, Favorable on our tests, recorded live 2026-08-242026-08-27: P/E 88.5, Favorable on our tests, recalculated for the week of 2026-08-272026-08-28: P/E 88.5, Favorable on our tests, recalculated for the week of 2026-08-282026-08-28: P/E 88.5, Favorable on our tests, recalculated for the week of 2026-08-302026-08-28: P/E 88.8, Favorable on our tests, recorded live 2026-08-312026-09-04: P/E 88.8, Favorable on our tests, recalculated for the week of 2026-09-052026-09-04: P/E 94.0, Mixed on our tests, recorded live 2026-09-072026-09-11: P/E 94.0, Mixed on our tests, recalculated for the week of 2026-09-122026-09-11: P/E 87.1, Favorable on our tests, recorded live 2026-09-142026-09-18: P/E 87.1, Favorable on our tests, recalculated for the week of 2026-09-192026-09-18: P/E 89.6, Mixed on our tests, recorded live 2026-09-212026-09-25: P/E 106.4, Mixed on our tests, recalculated for the week of 2026-09-262026-09-25: P/E 106.4, Mixed on our tests, recorded live 2026-09-282026-10-02: P/E 101.0, Mixed on our tests, recalculated for the week of 2026-10-032026-10-02: P/E 101.0, Mixed on our tests, recorded live 2026-10-052026-10-09: P/E 97.5, Mixed on our tests, recalculated for the week of 2026-10-102026-10-09: P/E 97.5, Mixed on our tests, recorded live 2026-10-12100.0120.0Jun 12Jul 12Aug 11Sep 9Oct 9Normal P/E 124.0
Favorable on our testsMixed on our testsWeak on forward returnsPoor on forward returnsLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekCurrent P/EPremium to normal P/ERating
2026-06-14P/E 95.7-23%Weak on forward returns (recalculated)
2026-07-22P/E 128.9+4%Poor on forward returns (recalculated)
2026-08-10P/E 106.6-14%Mixed on our tests
2026-08-24P/E 88.5-29%Favorable on our tests
2026-09-07P/E 94.0-24%Mixed on our tests
2026-09-14P/E 87.1-30%Favorable on our tests
2026-09-21P/E 89.6-28%Mixed on our tests
2026-10-12P/E 97.5-21%Mixed on our tests ← now
Show all 37 weeks
WeekCurrent P/EPremium to normal P/ERating
2026-06-14P/E 95.7-23%Weak on forward returns (recalculated)
2026-06-16P/E 95.7-23%Weak on forward returns (recalculated)
2026-06-21P/E 95.7-23%Weak on forward returns (recalculated)
2026-07-02P/E 95.7-23%Weak on forward returns (recalculated)
2026-07-06P/E 95.7-23%Weak on forward returns (recalculated)
2026-07-09P/E 95.7-23%Weak on forward returns (recalculated)
2026-07-12P/E 95.7-23%Weak on forward returns (recalculated)
2026-07-13P/E 95.7-23%Weak on forward returns (recalculated)
2026-07-14P/E 95.7-23%Weak on forward returns (recalculated)
2026-07-20P/E 95.7-23%Weak on forward returns (recalculated)
2026-07-22P/E 128.9+4%Poor on forward returns (recalculated)
2026-07-25P/E 128.9+4%Poor on forward returns (recalculated)
2026-07-27P/E 128.9+4%Poor on forward returns (recalculated)
2026-07-31P/E 128.9+4%Poor on forward returns (recalculated)
2026-08-03P/E 123.2-1%Poor on forward returns
2026-08-07P/E 123.2-1%Poor on forward returns (recalculated)
2026-08-10P/E 106.6-14%Mixed on our tests
2026-08-14P/E 106.6-14%Mixed on our tests (recalculated)
2026-08-17P/E 101.2-18%Mixed on our tests
2026-08-21P/E 101.2-18%Mixed on our tests (recalculated)
2026-08-24P/E 88.5-29%Favorable on our tests
2026-08-27P/E 88.5-29%Favorable on our tests (recalculated)
2026-08-28P/E 88.5-29%Favorable on our tests (recalculated)
2026-08-30P/E 88.5-29%Favorable on our tests (recalculated)
2026-08-31P/E 88.8-28%Favorable on our tests
2026-09-05P/E 88.8-28%Favorable on our tests (recalculated)
2026-09-07P/E 94.0-24%Mixed on our tests
2026-09-12P/E 94.0-24%Mixed on our tests (recalculated)
2026-09-14P/E 87.1-30%Favorable on our tests
2026-09-19P/E 87.1-30%Favorable on our tests (recalculated)
2026-09-21P/E 89.6-28%Mixed on our tests
2026-09-26P/E 106.4-14%Mixed on our tests (recalculated)
2026-09-28P/E 106.4-14%Mixed on our tests
2026-10-03P/E 101.0-19%Mixed on our tests (recalculated)
2026-10-05P/E 101.0-19%Mixed on our tests
2026-10-10P/E 97.5-21%Mixed on our tests (recalculated)
2026-10-12P/E 97.5-21%Mixed on our tests ← now

Frequently asked questions

Is Astera Labs stock overvalued?

At a current P/E of 97.5 versus its historical normal P/E of 124.0, Astera Labs trades about 21% below its typical valuation, with a PEG of 2.14 on 45.6% forward growth. tickerseer currently rates it mixed on our tests.

What is Astera Labs's fair value and PEG?

Astera Labs trades at a current P/E of 97.5 against a historical normal P/E of 124.0, a PEG of 2.14, and a forward growth estimate of 45.6%. Priced at its historical normal P/E of 124.0 on the same blended earnings, the 2026-10-09 close of $342.21 corresponds to about $435 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Astera Labs changed?

tickerseer's rating moved from weak on forward returns (2026-06-14) to mixed on our tests (2026-10-12).

What is the analyst price target for Astera Labs?

The mean Wall Street price target for Astera Labs is $391.77 across 22 analysts, 20.9% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Chipmakers. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track ALAB free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.